Macquarie Group LTD Bio Rad Laboratories, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

A detailed history of Macquarie Group LTD transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,128 shares of BIO stock, worth $385,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,128
Previous 2,158 47.73%
Holding current value
$385,223
Previous $589,000 35.99%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$263.97 - $344.64 $271,889 - $354,979
-1,030 Reduced 47.73%
1,128 $377,000
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $46,933 - $56,632
134 Added 6.62%
2,158 $773,000
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $81,963 - $110,899
-228 Reduced 10.12%
2,024 $767,000
Q3 2022

Nov 14, 2022
SELL
$412.59 - $563.26 $98,196 - $134,055
-238 Reduced 9.56%
2,252 $940,000
Q2 2022

Aug 15, 2022
BUY
$463.67 - $597.16 $172,948 - $222,740
373 Added 17.62%
2,490 $1.23 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $4,196 - $5,883
8 Added 0.38%
2,117 $1.19 Million
Q4 2021

Feb 11, 2022
SELL
$708.84 - $794.68 $471,378 - $528,462
-665 Reduced 23.97%
2,109 $1.59 Million
Q3 2021

Nov 12, 2021
SELL
$657.71 - $825.77 $159,165 - $199,836
-242 Reduced 8.02%
2,774 $2.07 Million
Q2 2021

Aug 13, 2021
BUY
$576.64 - $649.04 $1.2 Million - $1.35 Million
2,084 Added 223.61%
3,016 $1.94 Million
Q4 2020

Feb 16, 2021
SELL
$510.68 - $643.45 $1.46 Million - $1.84 Million
-2,859 Reduced 75.42%
932 $543,000
Q3 2020

Nov 13, 2020
BUY
$454.43 - $535.6 $212,218 - $250,125
467 Added 14.05%
3,791 $1.95 Million
Q2 2020

Aug 11, 2020
BUY
$334.87 - $493.06 $912,185 - $1.34 Million
2,724 Added 454.0%
3,324 $1.5 Million
Q4 2019

Feb 14, 2020
SELL
$319.73 - $374.2 $223,811 - $261,940
-700 Reduced 53.85%
600 $222,000
Q2 2019

Aug 14, 2019
BUY
$286.93 - $312.59 $301,276 - $328,219
1,050 Added 420.0%
1,300 $406,000
Q1 2019

May 15, 2019
SELL
$224.3 - $317.41 $2 Million - $2.84 Million
-8,935 Reduced 97.28%
250 $76,000
Q4 2018

Feb 15, 2019
SELL
$220.1 - $309.0 $1.49 Million - $2.1 Million
-6,789 Reduced 42.5%
9,185 $2.13 Million
Q3 2018

Nov 15, 2018
BUY
$289.28 - $326.15 $249,359 - $281,141
862 Added 5.7%
15,974 $5 Million
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $3.69 Million - $4.59 Million
15,112 New
15,112 $4.36 Million
Q1 2018

May 11, 2018
SELL
$233.97 - $274.11 $273,744 - $320,708
-1,170 Closed
0 $0
Q4 2017

Feb 15, 2018
BUY
$216.94 - $271.3 $4,338 - $5,426
20 Added 1.74%
1,170 $279,000
Q3 2017

Nov 08, 2017
BUY
$212.27 - $242.28 $244,110 - $278,622
1,150
1,150 $255,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email